CN104288270A - Traditional Chinese medicine composition for treating thrombophlebitis, and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating thrombophlebitis, and preparation method thereof Download PDFInfo
- Publication number
- CN104288270A CN104288270A CN201410181801.2A CN201410181801A CN104288270A CN 104288270 A CN104288270 A CN 104288270A CN 201410181801 A CN201410181801 A CN 201410181801A CN 104288270 A CN104288270 A CN 104288270A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- thrombophlebitis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 201000005060 thrombophlebitis Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 241000756943 Codonopsis Species 0.000 claims abstract description 20
- 241000218176 Corydalis Species 0.000 claims abstract description 20
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 241000628997 Flos Species 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000006187 pill Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 33
- 210000004369 blood Anatomy 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 22
- 230000008961 swelling Effects 0.000 abstract description 13
- 230000006870 function Effects 0.000 abstract description 7
- 244000144730 Amygdalus persica Species 0.000 abstract description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 241000158723 Melia Species 0.000 abstract description 2
- 240000000233 Melia azedarach Species 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 206010042674 Swelling Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 210000003141 lower extremity Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- -1 α and β-Humuleno Chemical compound 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 206010046996 Varicose vein Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000027185 varicose disease Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229960003742 phenol Drugs 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 3
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- UXYJCYXWJGAKQY-HNNXBMFYSA-N (S)-stylopine Chemical compound C1C2=C3OCOC3=CC=C2C[C@@H]2N1CCC1=C2C=C(OCO2)C2=C1 UXYJCYXWJGAKQY-HNNXBMFYSA-N 0.000 description 2
- KDFKJOFJHSVROC-INIZCTEOSA-N (S)-tetrahydrocolumbamine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(O)=C2 KDFKJOFJHSVROC-INIZCTEOSA-N 0.000 description 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- GVZVHYFESLXAML-YRNVUSSQSA-N 3-[2-(dimethylamino)ethyl]-6-methoxy-2-[(E)-2-(4-methoxyphenyl)ethenyl]phenol Chemical compound O(C)c1c(O)c(/C=C/c2ccc(OC)cc2)c(CCN(C)C)cc1 GVZVHYFESLXAML-YRNVUSSQSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- RFKQJTRWODZPHF-UHFFFAOYSA-N Dehydrocorydaline Chemical compound COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C(C)=C3C2=C1 RFKQJTRWODZPHF-UHFFFAOYSA-N 0.000 description 2
- ONFPYGOMAADWAT-OXUZYLMNSA-N Dehydroeburicoic acid Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)CC[C@@]4(C)C3=CC[C@H]21 ONFPYGOMAADWAT-OXUZYLMNSA-N 0.000 description 2
- GZZPOFFXKUVNSW-UHFFFAOYSA-N Dodecenoic acid Natural products OC(=O)CCCCCCCCCC=C GZZPOFFXKUVNSW-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 241001529246 Platymiscium Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 2
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- BWORNNDZQGOKBY-UHFFFAOYSA-N ombuin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(OC)C(O)=C1 BWORNNDZQGOKBY-UHFFFAOYSA-N 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- MUKYVRVYBBYJSI-UHFFFAOYSA-N protosappanin A Chemical compound O1CC(=O)CC2=CC(O)=C(O)C=C2C2=CC=C(O)C=C12 MUKYVRVYBBYJSI-UHFFFAOYSA-N 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 2
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- USDOQCCMRDNVAH-KKUMJFAQSA-N β-cadinene Chemical compound C1C=C(C)C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 USDOQCCMRDNVAH-KKUMJFAQSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- OBVLTWCOTSTMNM-FKIZINRSSA-N (13s,13ar)-2,9,10-trimethoxy-13-methyl-6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinolin-3-ol Chemical compound C1([C@@H]2C)=CC=C(OC)C(OC)=C1CN1[C@H]2C(C=C(C(=C2)O)OC)=C2CC1 OBVLTWCOTSTMNM-FKIZINRSSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- GEHGAWHOBGXBGC-MIUHORAWSA-N (1s,3r,5r,7r,8s,9s,10s,12r,13s,14s,17r)-17-(furan-3-yl)-1,7,20-trihydroxy-4,8,13-trimethyl-11,15-dioxohexadecahydro-4,10-(methanooxymethano)cyclopenta[a]phenanthrene-3,12-diyl diacetate Chemical compound C=1([C@@H]2CC(=O)[C@H]3[C@]4(C)[C@H](O)C[C@H]5C6(C)C(O)OC[C@]5([C@H]4C(=O)[C@H](OC(C)=O)[C@]32C)[C@@H](O)C[C@H]6OC(=O)C)C=COC=1 GEHGAWHOBGXBGC-MIUHORAWSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- DABHSVCBZNIZDT-WFJMIKGLSA-N (2r,5r)-5-(3,3-dimethyloxiran-2-yl)-3-[(3s,9r,10r,13s,14s,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]oxolan-2-ol Chemical compound CC1(C)OC1[C@@H]1O[C@@H](O)C([C@@H]2[C@@]3(CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC=C4[C@@]3(C)CC2)C)C1 DABHSVCBZNIZDT-WFJMIKGLSA-N 0.000 description 1
- KQQFKZUGBOQKLW-NGJRWZKOSA-N (2s,3s,4s,5r)-2-ethoxy-2,5-bis(hydroxymethyl)oxolane-3,4-diol Chemical compound CCO[C@@]1(CO)O[C@H](CO)[C@@H](O)[C@@H]1O KQQFKZUGBOQKLW-NGJRWZKOSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- JUJOJJFIOBKCID-MRXNPFEDSA-N (3r)-3-[(3,4-dihydroxyphenyl)methyl]-3,7,8-trihydroxy-2h-chromen-4-one Chemical compound C1=C(O)C(O)=CC=C1C[C@]1(O)C(=O)C2=CC=C(O)C(O)=C2OC1 JUJOJJFIOBKCID-MRXNPFEDSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- PQECCKIOFCWGRJ-HNNXBMFYSA-N (S)-nandinine Chemical compound C1=C2[C@@H]3CC4=CC=C(OC)C(O)=C4CN3CCC2=CC2=C1OCO2 PQECCKIOFCWGRJ-HNNXBMFYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- JOQZKEFBHIMDMX-UHFFFAOYSA-N 12alpha-hydroxyamoorastatone Natural products CC(=O)OC1CC(O)C23COC(O)C1(C)C2CC(O)C4(C)C5C(=O)CC(c6cocc6)C5(C)C(O)C(=O)C34 JOQZKEFBHIMDMX-UHFFFAOYSA-N 0.000 description 1
- ICWHTQRTTHCUHW-IPYPFGDCSA-N 2-[(3s,5r,6r)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol Chemical compound C[C@@H]1CCC=C(C)[C@]11C[C@@H](C(C)(C)O)CC1 ICWHTQRTTHCUHW-IPYPFGDCSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- FEGVSPGUHMGGBO-UHFFFAOYSA-N 3-(2-methoxyphenyl)-2-propenoic acid Chemical compound COC1=CC=CC=C1C=CC(O)=O FEGVSPGUHMGGBO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- ICWHTQRTTHCUHW-UHFFFAOYSA-N Agarospirol Natural products CC1CCC=C(C)C11CC(C(C)(C)O)CC1 ICWHTQRTTHCUHW-UHFFFAOYSA-N 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- IYGYMKDQCDOMRE-QRWMCTBCSA-N Bicculine Chemical compound O([C@H]1C2C3=CC=4OCOC=4C=C3CCN2C)C(=O)C2=C1C=CC1=C2OCO1 IYGYMKDQCDOMRE-QRWMCTBCSA-N 0.000 description 1
- 244000036978 Caesalpinia bonduc Species 0.000 description 1
- 235000014145 Caesalpinia bonduc Nutrition 0.000 description 1
- 235000009133 Caesalpinia coriaria Nutrition 0.000 description 1
- 235000005082 Caesalpinia paraguariensis Nutrition 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- 241000614992 Codonopsis subglobosa Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- DABHSVCBZNIZDT-UHFFFAOYSA-N Deacetylturraeanthin Natural products CC1(C)OC1C1OC(O)C(C2C3(CCC4C5(C)CCC(O)C(C)(C)C5CC=C4C3(C)CC2)C)C1 DABHSVCBZNIZDT-UHFFFAOYSA-N 0.000 description 1
- ONFPYGOMAADWAT-UHFFFAOYSA-N Dehydroeburicolic acid Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC4(C)C3=CCC21 ONFPYGOMAADWAT-UHFFFAOYSA-N 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- QOEHNLSDMADWEF-UHFFFAOYSA-N I-Dotriacontanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO QOEHNLSDMADWEF-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GEHGAWHOBGXBGC-UHFFFAOYSA-N Isotoosendanin Natural products CC(=O)OC1CC(O)C2(C3C(=O)C(OC(C)=O)C45C)COC(O)C1(C)C2CC(O)C3(C)C4C(=O)CC5C=1C=COC=1 GEHGAWHOBGXBGC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 244000303199 Lamium album Species 0.000 description 1
- 235000009199 Lamium album Nutrition 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241001570521 Lonicera periclymenum Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- WJHSRFQBVYHKKL-UHFFFAOYSA-N Oroboside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(C=3C=C(O)C(O)=CC=3)=COC2=C1 WJHSRFQBVYHKKL-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- 244000010916 Prunus canescens Species 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- CVBNMWXECPZOLM-UHFFFAOYSA-N Rhamnetin Natural products COc1cc(O)c2C(=O)C(=C(Oc2c1)c3ccc(O)c(O)c3O)O CVBNMWXECPZOLM-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- PQECCKIOFCWGRJ-UHFFFAOYSA-N Tetrahydro-berberine Natural products C1=C2C3CC4=CC=C(OC)C(O)=C4CN3CCC2=CC2=C1OCO2 PQECCKIOFCWGRJ-UHFFFAOYSA-N 0.000 description 1
- OBVLTWCOTSTMNM-UHFFFAOYSA-N Tetrahydrocorybulbin Natural products CC1C2=CC=C(OC)C(OC)=C2CN2C1C(C=C(C(=C1)O)OC)=C1CC2 OBVLTWCOTSTMNM-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043595 Thrombophlebitis superficial Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- NAHTXVIXCMUDLF-DUJPAFNYSA-N Toosendanin Natural products O=C(O[C@H]1C(=O)[C@H]2[C@@](C)([C@H](O)C[C@H]3[C@@]4(C)[C@H](O)OC[C@@]23[C@@H](O)C[C@H]4OC(=O)C)[C@@]23[C@]1(C)[C@H](c1cocc1)C[C@H]2O3)C NAHTXVIXCMUDLF-DUJPAFNYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000746966 Zizania Species 0.000 description 1
- 235000002636 Zizania aquatica Nutrition 0.000 description 1
- BJXXCOMGRRCAGN-CLFAGFIQSA-N [2,2-bis(hydroxymethyl)-3-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCC\C=C/CCCCCCCC BJXXCOMGRRCAGN-CLFAGFIQSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- HYBRYAPKQCZIAE-UHFFFAOYSA-N allocryptopine Chemical compound C1=C2CCN(C)CC3=C(OC)C(OC)=CC=C3CC(=O)C2=CC2=C1OCO2 HYBRYAPKQCZIAE-UHFFFAOYSA-N 0.000 description 1
- NGFLTEGALWMQIJ-UHFFFAOYSA-N allocryptopine Natural products COc1ccc2CC(=O)c3cc4OCOc4cc3CN(C)CCc2c1OC NGFLTEGALWMQIJ-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- HUIJAZQRYSCNED-UHFFFAOYSA-N alpha-allo-cryptopine Natural products C1CN(C)CC2=C(OC)C(OC)=CC=C2CC(=O)C2=CC(OC)=C(OC)C=C21 HUIJAZQRYSCNED-UHFFFAOYSA-N 0.000 description 1
- QMAYBMKBYCGXDH-UHFFFAOYSA-N alpha-amorphene Natural products C1CC(C)=CC2C(C(C)C)CC=C(C)C21 QMAYBMKBYCGXDH-UHFFFAOYSA-N 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003409 anti-rejection Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- AACMFFIUYXGCOC-UHFFFAOYSA-N bicuculline Natural products CN1CCc2cc3OCOc3cc2C1C4OCc5c6OCOc6ccc45 AACMFFIUYXGCOC-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- YYFOFDHQVIODOQ-UHFFFAOYSA-O columbamine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)O)OC)CC3)[N+]3=CC2=C1OC YYFOFDHQVIODOQ-UHFFFAOYSA-O 0.000 description 1
- CYOURJWVXZHEPP-UHFFFAOYSA-N columbamine Natural products COc1cc2CCN3Cc4c(OC)c(OC)ccc4C=C3c2cc1O CYOURJWVXZHEPP-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- XPOJSWHIKCNLEQ-UHFFFAOYSA-N cryptopine Chemical compound C1CN(C)CC2=C(OCO3)C3=CC=C2CC(=O)C2=C1C=C(OC)C(OC)=C2 XPOJSWHIKCNLEQ-UHFFFAOYSA-N 0.000 description 1
- RHJBGPMDJNBXPF-UHFFFAOYSA-N cryptopine Natural products COc1cc2CCN(C)c3cc4OCOc4cc3CCC(=O)c2cc1OC RHJBGPMDJNBXPF-UHFFFAOYSA-N 0.000 description 1
- IYGYMKDQCDOMRE-UHFFFAOYSA-N d-Bicucullin Natural products CN1CCC2=CC=3OCOC=3C=C2C1C1OC(=O)C2=C1C=CC1=C2OCO1 IYGYMKDQCDOMRE-UHFFFAOYSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- DVXFDXIVWQWLIU-UHFFFAOYSA-N dehydroeburiconic acid Natural products CC1(C)C(=O)CCC2(C)C3=CCC4(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC4(C)C3=CCC21 DVXFDXIVWQWLIU-UHFFFAOYSA-N 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- RZUHGAKUNBFQJS-UHFFFAOYSA-N didehydroglaucine Natural products COC1=C(OC)C2=C(C=C(C(OC)=C3)OC)C3=CC(N(C)CC3)=C2C3=C1 RZUHGAKUNBFQJS-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 1
- 229940090028 ethyl linolenate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-UHFFFAOYSA-N ethyl linolenate Natural products CCOC(=O)CCCCCCCC=CCC=CCC=CCC JYYFMIOPGOFNPK-UHFFFAOYSA-N 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- KQQFKZUGBOQKLW-UHFFFAOYSA-N ethyl-beta-D-fructofuranoside Natural products CCOC1(CO)OC(CO)C(O)C1O KQQFKZUGBOQKLW-UHFFFAOYSA-N 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- ZOLPMMWNCLHKPX-UHFFFAOYSA-N ligustrin Natural products CC1=CCC2C1C3OC(=C)C(=O)C3C(O)CC2=C ZOLPMMWNCLHKPX-UHFFFAOYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DABHSVCBZNIZDT-JJDPDEBESA-N melianol Natural products CC1(C)O[C@H]1[C@H]1C[C@H]([C@H](O)O1)[C@@H]1CC[C@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C DABHSVCBZNIZDT-JJDPDEBESA-N 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000715 neuromuscular junction Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 150000002919 oxepanes Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- XXLFLUJXWKXUGS-UHFFFAOYSA-N quininic acid Natural products N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- JGUZGNYPMHHYRK-UHFFFAOYSA-N rhamnetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 JGUZGNYPMHHYRK-UHFFFAOYSA-N 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008492 tangshen Substances 0.000 description 1
- 229930183580 tangshenoside Natural products 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- KDFKJOFJHSVROC-UHFFFAOYSA-N tetrahydrocolumbamine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(O)=C2 KDFKJOFJHSVROC-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- NAHTXVIXCMUDLF-RFNFAWMESA-N toosendanin Chemical compound C=1([C@H]2[C@]3(C)[C@@H](OC(C)=O)C(=O)[C@H]4[C@@]([C@@]53O[C@@H]5C2)(C)[C@H](O)C[C@H]2[C@@]3(C)[C@H](O)OC[C@]24[C@@H](O)C[C@H]3OC(=O)C)C=COC=1 NAHTXVIXCMUDLF-RFNFAWMESA-N 0.000 description 1
- 239000008488 toosendanin Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- PVYYNJAXBCIMNG-FKIZINRSSA-N yuanhunine Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(O)=C1OC PVYYNJAXBCIMNG-FKIZINRSSA-N 0.000 description 1
- PVYYNJAXBCIMNG-UHFFFAOYSA-N yuanhunine Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(O)=C2OC PVYYNJAXBCIMNG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating thrombophlebitis, and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is composed of the following raw materials by weight: 10-20 parts of poria, 10-15 parts of white atractylodes rhizome, 5-15 parts of radix codonopsis, 20-30 parts of radix astragali, 15-20 parts of Chinese angelica root, 10-20 parts of red peony root, 5-15 parts of peach kernels, 5-15 parts of safflower, 5-15 parts of sappanwood, 10-20 parts of cassia twig, 15-20 parts of honeysuckle, 10-20 parts of rhizoma corydalis and 10-20 parts of melia toosendan. On basis of a theory of traditional Chinese medicine, the traditional Chinese medicine composition combines a formula according to a sovereign, minister, assistant and envoy principle. In the formula, the poria, radix codonopsis and safflower are used as sovereign drugs which have the function of activating blood to resolve stasis; the honeysuckle, rhizoma corydalis and melia toosenedan are used as minister drugs which have the function of regulating lipid; and the red peony root, peach kernels and cassia twig are used as envoy drugs which have the functions of coordinating all the drugs, dispersing swelling and enhancing immunity of a patient. The traditional Chinese medicine composition is mainly used for treating the thrombophlebitis, particularly for sore symptoms of a thrombophlebitis patient, and has a definite curative effect.
Description
Technical field
The present invention is specifically related to a kind of Chinese medicine composition being used for the treatment of thrombophlebitis, and the preparation method of this Chinese medicine composition, belongs to technical field of Chinese medicine.
Background technology
Thrombophlebitis is the commonly encountered diseases of peripheral-vascular, accompanies thrombosis by the inflammation in venous lumen simultaneously.Clinical manifestation is limbs local swelling, and color of the leather is secretly blue or green, blood stasis and pain.Thrombophlebitis belongs to the categories such as the superficial obstructive phlebitis of Chinese medicine, blood vessel, yellow loach pain, table snake venom, and the factors such as the generation of primary disease is manyly stagnated by damp-heat accumulation, cold temperature, wound passages through which vital energy circulates of it is generally acknowledged cause QI and blood to be driven in the wrong direction in smooth, stasis arteries and veins.There are some researches prove all kinds thrombophlebitis blood samples of patients all in hypercoagulability, blood denseness increases, slow blood flow is thrombotic pathologic basis, after thrombosis, the secondary hemopoietic bolt of proximad expansion and distally procreation, excite the inflammation around wall of vein and vein with blood vessel wall adhesion gradually, thus form thrombotic.
At present, the treatment by Chinese herbs method of clinical treatment thrombophlebitis master comprises quiet of interior oral administration, application and Chinese medicine.The multiple blood-activating stasis-removing kind Chinese medicine of the many uses of interior oral administration is as Radix Notoginseng etc., and the Chinese medicine of many some irritation effect of use of application is as Fructus Capsici, and these two kinds of Therapeutic Method all exist the shortcoming that uncertain therapeutic efficacy is cut, treatment cycle is long.Using Radix Notoginseng, the components in danshen Chinese medicine with function of promoting blood circulation to disperse blood clots quiet more, the method is rapid-action, but there is certain bleeding risk when the long period uses in such Chinese medicine, and its exist use inconvenient, costly, the defect that easily recurs of drug withdrawal.Clinical for meeting better, urgently a kind of curative effect certainly, toxic and side effects little, easy to use and patient's economic capability Chinese medicine preparation for the treatment of thrombophlebitis that can bear.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition being used for the treatment of thrombophlebitis.
Meanwhile, the present invention also provides a kind of preparation method being used for the treatment of the Chinese medicine composition of thrombophlebitis.
In order to realize above object, the technical solution adopted in the present invention is:
Be used for the treatment of a Chinese medicine composition for thrombophlebitis, be made up of the crude drug of following parts by weight: Poria 10 ~ 20 parts, the Rhizoma Atractylodis Macrocephalae 10 ~ 15 parts, Radix Codonopsis 5 ~ 15 parts, the Radix Astragali 20 ~ 30 parts, Radix Angelicae Sinensis 15 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, 5 ~ 15 parts, Semen Persicae, 5 ~ 15 parts, Flos Carthami, Lignum Sappan 5 ~ 15 parts, Ramulus Cinnamomi 10 ~ 20 parts, Flos Lonicerae 15 ~ 20 parts, Rhizoma Corydalis 10 ~ 20 parts, Fructus Toosendan 10 ~ 20 parts.
Preferably, be used for the treatment of the Chinese medicine composition of thrombophlebitis, be made up of the crude drug of following parts by weight: Poria 15 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Radix Codonopsis 10 parts, the Radix Astragali 25 parts, Radix Angelicae Sinensis 18 parts, Radix Paeoniae Rubra 15 parts, 10 parts, Semen Persicae, 10 parts, Flos Carthami, Lignum Sappan 10 parts, Ramulus Cinnamomi 15 parts, Flos Lonicerae 18 parts, Rhizoma Corydalis 15 parts, Fructus Toosendan 12 parts.
Each crude drug effect is summarized as follows:
Poria: for Polyporaceae hole of crouching belongs to the sclerotium of fungus Poria; Containing triterpenes as pachymic acid, 16 Alpha-hydroxy eburicoic acids, β-para hydroxybenzene acyl group dehydroeburicoic acid etc., polysaccharide as the callose etc. of pachyman, pachymaran and height, branch, also containing the various active composition such as ergosterol, sad, hendecanoic acid, lauric acid, dodecenoic acid, Palmic acid, dodecenoic acid fat, sad fat and inorganic elements; Nature and flavor are sweet, light, flat, GUIXIN, spleen, lung, kidney channel; Energy promoting diuresis to eliminate damp pathogen, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; Cure mainly dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, have loose bowels, palpitation and restlessness, insomnia forgetfulness etc.; Modern pharmacology proves that Poria has diuresis, anticancer and immunological enhancement etc.
The Rhizoma Atractylodis Macrocephalae: be the rhizome of the Compositae [WTBX plant Rhizoma Atractylodis Macrocephalae; Containing volatile oil as atractylone, α and β-Humuleno, α-curcumene, Palmic acid, hinesol etc., sesquiterpene lactones compound is as atractyloide-I, II, III, IV etc., polyacetylene alcohol compound, also containing scopoletin, there is immunocompetent mannan AM-3, and more than ten seed amino acid such as aspartic acid, serine; Rhizoma Atractylodis Macrocephalae nature and flavor are bitter, sweet, and temperature, returns spleen, stomach warp; Can invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive; Cure mainly weak, the lack of appetite abdominal distention of deficiency-weakness of spleen-QI, have loose bowels, constipation, fluid-retention stagnating in the interior dysuria, edema, dizziness due to fluid-retention, Korean style numbness, general pain, spontaneous sweating due to deficiency of QI etc.; Modern pharmacology proves the effects such as the Rhizoma Atractylodis Macrocephalae has antioxidation and slow down aging, antitumor, blood sugar lowering, diuresis and anti-ascites, protects the liver, function of gallbladder promoting, can also facilitating digestion system, immune system, cardiac muscle and cardiovascular system.
Radix Codonopsis: be the root of campanulaceae Codonopsis plant Radix Codonopsis, element flower Radix Codonopsis, radix codonpsis tangshen, pipe flower Radix Codonopsis, C. subglobosa, C. canescens; Containing saccharide as fructose, inulin, polysaccharide and 4 kinds of heteropolysaccharide CP
1, CP
2, CP
3, CP
4glycoside is as ligustrin, n-hexyl-β-pyranglucoside, ethyl-α-D-fructofuranoside, tangshenoside, alkaloid and nitrogen containing component, as choline, loline etc., also contain the various active compositions such as syringic aldehyde, vanillic acid, pyromucic acid, atractyloide I, II; Radix Codonopsis nature and flavor are sweet, flat, return spleen, lung meridian; Energy strengthening the spleen and tonifying the lung, supplementing QI for promoting the production of body fluid; Cure mainly weakness of the spleen and stomach, anorexia and loose stool, limbs fatigue, the deficiency of the lung are breathed with cough, all cards of spontaneous perspiration of breathing hard, deficiency of both QI and blood; Modern pharmacology proves that Radix Codonopsis has enhancing body stress ability, enhancing human body immunity function, slow down aging, antiulcer, antitumor assosting effect etc.
The Radix Astragali: be the root of pulse family Astragalus Radix Astagali and Radix Astragali; Containing saponin component as astragaloside, isoflavones components is as calycosin, and fatty acid is as Palmic acid and linoleic acid, and polysaccharide is as astragalus polysaccharides, heteropolysaccharide etc., and nearly 20 various trace elements; Radix Astragali nature and flavor are sweet, and temperature, returns lung, spleen channel; Energy benefiting qi and raising yang, strengthening superficial resistance to stop perspiration, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening; Cure mainly the disease of all Qi and blood deficiencies, as diarrhea due to hypofunction of the spleen, cough due to deficiency of the lung, proctoptosis, uterine prolapse, spontaneous perspiration, night sweat, edema, arthralgia due to stagnation of blood, carbuncle difficulty is burst or is burst for a long time and do not hold back; Modern pharmacology proves that the Radix Astragali can affect organism metabolism, has the effects such as antioxidation, antithrombotic, antiviral, arthritis, anticancer, anti-inflammatory and antalgic, can also protect cardio-cerebrovascular and promote hemopoietic function.
Radix Angelicae Sinensis (Radix Angelicae Sinensis): when being classified as the root of Umbelliferae archangel Radix Angelicae Sinensis; Containing multiple volatile oil and organic acid, also containing more than 20 kind of inorganic elements and polysaccharide composition; Radix Angelicae Sinensis nature and flavor are sweet, pungent, bitter, and temperature, returns liver, the heart, spleen channel; Can enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, moisturize laxation; Cure mainly all cards of blood deficiency, menoxenia, amenorrhea, dysmenorrhea , mass in the abdomen knot is poly-, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, numbness of the skin, dryness of the intestine dyschezia, heavy after bloody dysentery, ulcer sores, injury from falling down etc.; Modern pharmacology proves that Radix Angelicae Sinensis can affect blood and hemopoietic system, has the effects such as blood fat reducing, arteriosclerosis, radioprotective, antitumor, anti-inflammatory and antalgic, antibody Monoclonal.Radix Angelicae Sinensis refers to the afterbody of Radix Angelicae Sinensis, has the effect such as blood circulation promoting and blood stasis dispelling, removing blood stasis, is applied to the stagnant disease such as to swell and ache of the obstructed and blood stasis of amenorrhea
Radix Paeoniae Rubra: be the root of Paeoniaceae Paeonia plant peony, river Radix Paeoniae Rubra; Containing monoterpenes as Radix Paeoniae Rubra glycosides, oxidation Radix Paeoniae Rubra glycosides etc., organic acid, as benzoic acid, gallic acid etc., also contains the plurality of active ingredients such as catechin, cupreol; Nature and flavor are bitter, be slightly cold, and return Liver Channel; Energy clearing away heat and cooling blood, clots absorbing pain relieving, dissipating blood stasis for subsidence of swelling; Cure mainly amenorrhea dysmenorrhea, hernia abdominal mass gathered, maculae caused by violent heat pathogen, hematemesis and epistaxis, hypochondriac pain due to stagnation of liverQI, discharging fresh blood stool, conjunctival congestion and swelling pain, injury from falling down, carbuncle
skin infection, can be used for the diseases such as amenorrhea; Modern pharmacology proves that Radix Paeoniae Rubra has antithrombotic, antiplatelet aggregation, arteriosclerosis, the effect such as to protect the liver.
Semen Persicae: be the seed of Rosaceae peach family plant seed Fructus Persicae or Prunus davidiana; Containing amygdaloside, Virginia prune glucoside etc., sterols is as cupreol, campesterol etc., and organic acid is if chlorogenic acid, 3-caffeoylquinic acid, 3-are to coumaric acyl quininic acid, triolein, oleic acid and linoleic acid etc., and protein is as PR-A and PR-B etc.; Nature and flavor are bitter, sweet, GUIXIN, liver, large intestine channel; Energy blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Cure mainly dysmenorrhea, amenorrhea due to stagnation of blood, the stasis of blood in puerperal stagnant stomachache, mass in the abdomen caking, traumatic injury, swelling and pain due to blood stasis, lung abscess, acute appendicitis, dryness of the intestine constipation etc.; Modern pharmacology proves that Semen Persicae has anticoagulation, antithrombus formation, antiinflammatory, eliminating phlegm and stopping cough, antitumor action etc.
Flos Carthami: be the flower of Compositae Flos Carthami platymiscium Flos Carthami; Containing flavone compound as saffloside, front saffloside, safflower yellow A, B etc., Polyphenols is as chlorogenic acid, caffeic acid, catechol etc., also plant volatile ingredient as methyl cinnamate, Flos Caryophylli alkene, Flos Caryophylli alkene epoxide etc. containing more than 80, and 16 seed amino acid as lysine, fatty acid is as Palmic acid, myristic acid, lauric acid, oleic acid etc., another containing Flos Carthami polysaccharide and other multiple active components; Nature and flavor are pungent, warm, GUIXIN, Liver Channel; Energy promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; Cure mainly blood stasis amenorrhea, dysmenorrhea, postpartum stagnation stomachache, obstruction of qi in the chest and cardialgia, lumps in the chest and abdomen, traumatic injury, arthralgia, apoplectic hemiplegia etc.; Modern pharmacology proves that Flos Carthami has anticoagulation, antiinflammatory, antioxidation etc.
Lignum Sappan: be the heartwood of pulse family divi divi platymiscium Lignum Sappan; Containing chromanane compounds as 3-deoxidation hematoxylone B, Lignum Sappan phenol, table Lignum Sappan phenol etc., also containing brazilin, brazilin derivant 1 and 2, contain again flavones ingredient as ombuin, rhamnetin, Quercetin etc., the another dibenzo oxepane compounds that contains is as protosappanin A, the former haematoxylin B of B, D, E-1, E-2 and 10-O-methyl, and Lignum Sappan bitter principle J and P, octacosanol, cupreol and taraxerol etc.; Nature and flavor are sweet, salty, micro-pungent, flat, GUIXIN, liver, large intestine channel; Energy blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain; Cure mainly married woman's amenorrhea due to stagnation of blood, dysmenorrhea, postpartum stagnation cardiac and abdominal pain, puerperal blood faints, carbuncle, traumatic injury, tetanus etc.; Modern pharmacology proves that Lignum Sappan has anticancer, immunosuppressant and anti-rejection effect, also has an impact to blood and blood circulation.
Ramulus Cinnamomi: be the twig of Lauraceae cinnamon Cortex Cinnamomi; Containing volatile oil as cinnamic aldehyde, benzyl benzoate, cinnamyl acetate, β-cadinene, Rhizoma Acori Graminei alkene, coumarin, cinnamic acid, o-methoxy-3-phenyl-2-propenoic acid, 1,4-diphenyl-diacetyl, syringic aldehyde, steroid is as cupreol, 5 α, 8 α-Ergosterol Peroxide, 6 beta-hydroxy-4-alkene-3-stigmasterones, again containing protocatechuic acid, daucosterol etc.; Nature and flavor acrid, sweet, warm, return bladder, the heart, lung meridian; Can expelling cold and relieving exterior syndrome, warming the meridian, activate yang; Cure mainly wind and cold sign, arthralgia due to cold-dampnes, extreme cold of the limbs, amenorrhea dysmenorrhea, mass in the abdomen caking, the thoracic obstruction, cardiopalmus, phlegm retention, dysuria etc.; Modern pharmacology proves that Ramulus Cinnamomi has the effects such as antibacterial, antiviral, antipyretic, analgesia, calmness, convulsion, antiinflammatory.
Flos Lonicerae (Radix Ophiopogonis): be the alabastrum of Caprifoliaceae woodbine Radix Ophiopogonis, Lonicera confusa, wild rice gland Radix Ophiopogonis, Lonicera fulvotnetosa Hsu et S. C. Cheng. Ms; Containing phenolic acids as chlorogenic acid, isochlorogenic acid, sterols is as cupreol, and volatile oil is as linalool, ethyl palmitate, ethyl linolenate etc., and flavonoid is as plurality of active ingredients such as luteoloside, xylostein, hyperins; Flos Lonicerae nature and flavor are sweet, cold; Attach to the lung and stomach meridians; Energy heat-clearing and toxic substances removing; Cure mainly affection due to external wind and heat or epidemic febrile disease heating, heatstroke, toxic-heat and blood stasis, carbuncle furuncle, sore throat, multi-infection disease etc.; Modern pharmacology proves that Flos Lonicerae has the effects such as resisting pathogenic microbes, antitoxin, antiinflammatory, blood fat reducing, serum cholesterol (Tc) and atherogenic index (AI) can also be reduced, improve high density lipoprotein level-cholesterol (HDL-C) content.
Rhizoma Corydalis (Rhizoma Corydalis, Rhizoma Corydalis): be the tuber of Papaveraceae Genus Corydalis Rhizoma Corydalis, containing dextrorotation corydaline (Corydaline), Tetrahydropalmatine (tetrahydropalmatine), l-Tetrahydrocoptisine (Rhizoma Corydalis D prime), palmatine, dehydroglaucin, protopine (Rhizoma Corydalis C prime), dextrorotation is papaverine also, α-allocryptopine (Rhizoma Corydalis Kui prime), left-handed tetrahydrocolumbamine, dextrorotation corybulbine, 13-Methylpalmatine, left-handed N-1, Columbamine, dextrorotation-N-methyllaurotetanine, yuanhunine, leonticine, 13-methyl-13,14-dihydro-[1,3, dehydrogenation nandinine, bicuculline, cryptocavine, the multiple alkaloid such as coptisine and berberine, nature and flavor are pungent, bitter, temperature, GUIXIN, liver, spleen channel, energy promoting blood circulation to remove blood stasis, promoting the circulation of QI to relieve pain, cure mainly obstruction of qi in the chest and cardialgia, epigastric pain, lumbago, colicky, dysmenorrhea, amenorrhea, mass in the abdomen, the stagnant stomachache of the stasis of blood in puerperal, traumatic injury etc., modern pharmacology proves that Rhizoma Corydalis has analgesia, hypnosis, calmness, stabilizes, coronary artery dilator, suppression heart, arrhythmia, antiulcer, anticoagulant, Ca2+ overloading, antioxidation, the effect such as raising learning capacity.
Fructus Toosendan (chinaberry is real): be the fruit of Meliaceae melia plant Fructus Toosendan; Containing Triterpenoid as Toosendanin, Fructus Toosendan ketone, ester melianol, 21-O-acetyl Fructus Toosendan triol, 21-O-methyl Fructus Toosendan pentol, violet incense ketoside, isochuanliansu, Fructus Toosendan element first and the second grade, phenylpropyl alcohol triol glycosides, as Fructus Toosendan glycosides A and B, also contains n-Triacontanoic acid, n-dotriacontanol, Palmiticacid etc.; Nature and flavor are bitter, cold, and mild toxicity, returns liver, stomach, small intestine meridian; Energy is soothing the liver to expel the heat-evil, promoting the circulation of QI to relieve pain, parasite killing; Cure mainly the gastral cavity abdomen pain over the hypochondriac region, hernia pain, abdominal pain due to worm stagnation, tinea capitis etc.; Modern pharmacology proves that Fructus Toosendan has transmission between block nerves neuromuscular junction, ascarifuge, the effect such as antibacterial.
Be used for the treatment of a Chinese medicine composition for thrombophlebitis, conventional method can be adopted to be prepared into the form of Chinese drug such as oral liquid, granule, powder, pill, tablet, capsule, drink after also can directly brewing.The change of dosage form does not affect the therapeutic effect of Chinese medicine composition.The present invention provides the preparation method of a kind of oral liquid and honeyed pill respectively.
Be used for the treatment of a preparation method for the Chinese medicine composition of thrombophlebitis, comprise the following steps: accurately get each crude drug according to parts by weight, add the water soaking of 3 ~ 5 times amount, concentrate after temperature fire decocts and obtain oral liquid.
Be used for the treatment of a preparation method for the Chinese medicine composition of thrombophlebitis, comprise the following steps: accurately get each crude drug according to parts by weight, pulverize, sieve after fine powder; Get fine powder and carry out sterilization treatment; Honey in adding in the fine powder of sterilizing, after heating mixing, refine obtains honeyed pill.
Described sieves as crossing 100 ~ 120 mesh sieves.
Described sterilising conditions is: sterilization treatment 25 ~ 35 minutes at 95 ~ 110 DEG C.
Described middle honey can be commercial goods, and conventional method also can be adopted to prepare; The addition of middle honey is 15 ~ 20% of fine powder quality.
Described heating-up temperature is 50 ~ 60 DEG C.
Beneficial effect of the present invention:
The present invention, according to theory of Chinese medical science, according to monarch principle composition of prescription, chooses the totally 13 taste pure natural Chinese herbal medicine such as Poria, the Rhizoma Atractylodis Macrocephalae, Radix Codonopsis, and in side, Poria, Radix Codonopsis, Flos Carthami are monarch drug, have effect of blood circulation promoting and blood stasis dispelling; Flos Lonicerae, Rhizoma Corydalis, Fructus Toosendan are ministerial drug, and tool adjusts effect of fat; Radix Paeoniae Rubra, Semen Persicae, Ramulus Cinnamomi, for making medicine, have coordinating the actions of various ingredients in a prescription, detumescence and strengthen effect of patient's resistance; Its formula is reasonable, emphasizes organic conception, is mainly used in treating thrombophlebitis, especially for the symptom that swells and ache of thrombophlebitis patient, and determined curative effect.The present invention adopts pure natural Chinese herbal medicine not add any chemicals, and long-term taking is several to have no side effect, and Chinese crude drug source is wide, cheap, economical and practical.
The preparation method being used for the treatment of the Chinese medicine composition of thrombophlebitis in the present invention is simple, and production cost is low, is suitable for large-scale industrial production and application.
Detailed description of the invention
Following embodiment is only described in further detail the present invention, but does not form any limitation of the invention.
Embodiment 1
Be used for the treatment of the Chinese medicine composition of thrombophlebitis in the present embodiment, be made up of the crude drug of following weight: Poria 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Radix Codonopsis 5 grams, the Radix Astragali 30 grams, Radix Angelicae Sinensis 15 grams, Radix Paeoniae Rubra 20 grams, 5 grams, Semen Persicae, 15 grams, Flos Carthami, Lignum Sappan 5 grams, Ramulus Cinnamomi 20 grams, Flos Lonicerae 15 grams, Rhizoma Corydalis 20 grams, Fructus Toosendan 10 grams.
Be used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis in the present embodiment, comprise the following steps: accurately get each crude drug according to weight, after adding the water soaking of 5 times amount, temperature fire decocts, and is concentrated into 300ml and namely obtains oral liquid.
The usage of oral liquid and consumption: oral, one day twice, a 50ml 15 days is a course for the treatment of, one after each meal.
Embodiment 2
Be used for the treatment of the Chinese medicine composition of thrombophlebitis in the present embodiment, be made up of the crude drug of following weight: Poria 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Codonopsis 5 grams, the Radix Astragali 20 grams, Radix Angelicae Sinensis 15 grams, Radix Paeoniae Rubra 10 grams, 5 parts, Semen Persicae, 5 grams, Flos Carthami, Lignum Sappan 5 grams, Ramulus Cinnamomi 10 grams, Flos Lonicerae 15 grams, Rhizoma Corydalis 10 grams, Fructus Toosendan 10 grams.
Be used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis in the present embodiment, comprise the following steps: accurately get each crude drug according to weight, be crushed to 100 order fine powders; By the fine powder after sieving in 105 DEG C of sterilization treatment 30 minutes; Every 100 grams of fine powders add middle sweet 20 grams, make the honeyed pill of every heavy 0.3g, 50 DEG C of dryings.
The usage of honeyed pill and consumption: oral, one day three times, one time 5, within 30 days, be a course for the treatment of.
Embodiment 3
Be used for the treatment of the Chinese medicine composition of thrombophlebitis in the present embodiment, be made up of the crude drug of following weight: Poria 20 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Radix Codonopsis 15 grams, the Radix Astragali 30 grams, Radix Angelicae Sinensis 20 grams, Radix Paeoniae Rubra 20 grams, 15 grams, Semen Persicae, 15 grams, Flos Carthami, Lignum Sappan 15 grams, Ramulus Cinnamomi 20 grams, Flos Lonicerae 20 grams, Rhizoma Corydalis 20 grams, Fructus Toosendan 20 grams.
Be used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis in the present embodiment, comprise the following steps: accurately get each crude drug according to weight, after adding the water soaking of 4 times amount, temperature fire decocts, and is concentrated into 400ml and namely obtains oral liquid.
The usage of oral liquid and consumption: oral, one day twice, a 50ml 15 days is a course for the treatment of, one after each meal.
Embodiment 4
Be used for the treatment of the Chinese medicine composition of thrombophlebitis in the present embodiment, be made up of the crude drug of following weight: Poria 15 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Codonopsis 10 grams, the Radix Astragali 25 grams, Radix Angelicae Sinensis 18 grams, Radix Paeoniae Rubra 15 grams, 10 grams, Semen Persicae, 10 grams, Flos Carthami, Lignum Sappan 10 grams, Ramulus Cinnamomi 15 grams, Flos Lonicerae 18 grams, Rhizoma Corydalis 15 grams, Fructus Toosendan 12 grams.
Be used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis in the present embodiment, comprise the following steps: accurately get each crude drug according to weight, be crushed to 120 order fine powders; By the fine powder after sieving in 100 DEG C of sterilization treatment 30 minutes; Every 100 grams of fine powders add middle sweet 15 grams, make the honeyed pill of every heavy 0.3g, 50 DEG C of dryings.
The usage of honeyed pill and consumption: oral, one day three times, one time 5, within 30 days, be a course for the treatment of.
Embodiment 5
Be used for the treatment of the Chinese medicine composition of thrombophlebitis in the present embodiment, be made up of the crude drug of following weight: Poria 20 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Codonopsis 15 grams, the Radix Astragali 20 grams, Radix Angelicae Sinensis 20 grams, Radix Paeoniae Rubra 10 grams, 15 grams, Semen Persicae, 5 grams, Flos Carthami, Lignum Sappan 15 grams, Ramulus Cinnamomi 10 grams, Flos Lonicerae 20 grams, Rhizoma Corydalis 10 grams, Fructus Toosendan 20 grams.
Be used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis in the present embodiment, comprise the following steps: accurately get each crude drug according to weight, after adding the water soaking of 3 times amount, temperature fire decocts, and is concentrated into 300ml and namely obtains oral liquid.
The usage of oral liquid and consumption: oral, one day twice, a 50ml 15 days is a course for the treatment of, one after each meal.
Test example
1, clinical trial
(1) physical data
Choose 120 routine varicose veins of the lower extremity and merge thrombophlebitis patient, with type 2 diabetes mellitus, diagnose clearly and recurrent exerbation, be divided into treatment group and matched group according to randomly assigne, often organize 30 examples.Patient is no significant difference (P > 0.05) in sex, age, severity extent etc., has comparability.
(2) Therapeutic Method
Matched group: at treatment underlying diseases simultaneously, conventional antiinflammatory, changes clothes wound, magnesium sulfate external application;
Treatment group 1: add on treatment of control group basis with the embodiment of the present invention 4 prepare honeyed pill, one day three times, one time 5;
Treatment group 2: add the oral liquid prepared by the embodiment of the present invention 1 on treatment of control group basis, one day twice, a 50ml, one after each meal;
Treatment group 3: add the oral liquid prepared by the embodiment of the present invention 5 on treatment of control group basis, one day twice, a 50ml, one after each meal.
The course for the treatment of of matched group and treatment group is 30 days.Two groups of patients are respectively at treating front and treatment venous blood collection on an empty stomach in latter 30 day early morning, and mensuration hemorheology index, therapeutic outcome refers to following table 1.
(3) curative effect determinate standard
Recovery from illness: Varicose veins superficial vein disappears substantially, lower limb not swelling, Chronic leg ulcer heals;
Effective: Varicose veins superficial vein is calm, lower limb not swelling, Chronic leg ulcer healing area > 3/4, the red work of granulation, without secretions;
Take a turn for the better: Varicose veins vein is calm, lower limb mild swelling, Chronic leg ulcer healing area > 1/2, the redder work of granulation, can have a small amount of secretions;
Effective: Varicose veins superficial vein is calm, lower limb mild swelling, Chronic leg ulcer healing area > 1/4;
Invalid: Varicose veins superficial vein is obvious, lower extremity swelling and distension, Chronic leg ulcer healing area < 1/4 even expands.
(4) therapeutic outcome
Table 1 Chinese medicine composition is to the therapeutic effect of thrombophlebitis
(5) conclusion
Treat after 30 days, the total effective rate for the treatment of group all more than 85%, higher than 71% of matched group; Meanwhile, after treatment group treatment, comparatively matched group is obvious for each hemorheology index decline degree, shows that Chinese medicine composition of the present invention has good therapeutical effect to thrombophlebitis.
During taking Chinese medicine all there is not the untoward reaction such as hepatic and renal function injure in patient, shows that Chinese medicine composition of the present invention has good safety.
2, model case
Case 1:
Mr. Liu, 41 years old, suffers from the varicosis more than ten years, hardens in local; cannot normal activity, through making a definite diagnosis patient for overworked, the varicosis caused of suffering from cold for a long time, cause superficial thrombophlebitis because of wound afterwards; it is rubescent that patient carrys out surrounding skin when institute goes to a doctor, and heating, has lump, touches a tender spot.At the acutely inflamed honeyed pill taken the embodiment of the present invention 4 and prepare that application antibiotic therapy trauma infection contamination causes simultaneously, take the transference cure of patient's swelling and pain after 30 days, the position of hardening is deliquescing gradually also, takes after 60 days movable normal.
Case 2:
Mrs Liu, 58 years old, continues irregular heating for many years, is up to 39 DEG C.Nearly two wheat harvesting periods carry out right lower extremity and swell and ache, can not walk, left lower extremity is from thigh root to the general swelling of foot, and skin is slightly in aubergine, temperature is lower slightly, without pitting edema, great saphenous vein slightly expansion and hardening, all the other ramus superficialis veins have no expansion, femoribus internus tenderness is obvious, at the antibiotic honeyed pill taken the embodiment of the present invention 1 and prepare of application simultaneously, take the transference cure of patient's swelling and pain after 30 days, activity is compared with normal also.
Claims (6)
1. be used for the treatment of a Chinese medicine composition for thrombophlebitis, it is characterized in that: be made up of the crude drug of following parts by weight: Poria 10 ~ 20 parts, the Rhizoma Atractylodis Macrocephalae 10 ~ 15 parts, Radix Codonopsis 5 ~ 15 parts, the Radix Astragali 20 ~ 30 parts, Radix Angelicae Sinensis 15 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, 5 ~ 15 parts, Semen Persicae, 5 ~ 15 parts, Flos Carthami, Lignum Sappan 5 ~ 15 parts, Ramulus Cinnamomi 10 ~ 20 parts, Flos Lonicerae 15 ~ 20 parts, Rhizoma Corydalis 10 ~ 20 parts, Fructus Toosendan 10 ~ 20 parts.
2. the Chinese medicine composition being used for the treatment of thrombophlebitis according to claim 1, is characterized in that: be made up of the crude drug of following parts by weight: Poria 15 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Radix Codonopsis 10 parts, the Radix Astragali 25 parts, Radix Angelicae Sinensis 18 parts, Radix Paeoniae Rubra 15 parts, 10 parts, Semen Persicae, 10 parts, Flos Carthami, Lignum Sappan 10 parts, Ramulus Cinnamomi 15 parts, Flos Lonicerae 18 parts, Rhizoma Corydalis 15 parts, Fructus Toosendan 12 parts.
3. one kind is used for the treatment of the preparation method of the Chinese medicine composition of thrombophlebitis as claimed in claim 1 or 2, it is characterized in that: comprise the following steps: accurately get each crude drug according to parts by weight, add the water soaking of 3 ~ 5 times amount, concentrate after temperature fire decocts and obtain oral liquid.
4. be used for the treatment of a preparation method for the Chinese medicine composition of thrombophlebitis as claimed in claim 1 or 2, it is characterized in that: comprise the following steps: accurately get each crude drug according to parts by weight, pulverize, sieve after fine powder; Get fine powder and carry out sterilization treatment; Honey in adding in the fine powder of sterilizing, after heating mixing, refine obtains honeyed pill.
5. the preparation method being used for the treatment of the Chinese medicine composition of thrombophlebitis according to claim 4, is characterized in that: described sterilising conditions is: sterilizing 25 ~ 35 minutes at 95 ~ 110 DEG C.
6. the preparation method being used for the treatment of the Chinese medicine composition of thrombophlebitis according to claim 4, is characterized in that: the addition of described middle honey is 15 ~ 20% of fine powder quality.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410181801.2A CN104288270B (en) | 2014-04-30 | 2014-04-30 | A kind of for Chinese medicine composition treating thrombophlebitis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410181801.2A CN104288270B (en) | 2014-04-30 | 2014-04-30 | A kind of for Chinese medicine composition treating thrombophlebitis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104288270A true CN104288270A (en) | 2015-01-21 |
CN104288270B CN104288270B (en) | 2016-08-17 |
Family
ID=52308382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410181801.2A Expired - Fee Related CN104288270B (en) | 2014-04-30 | 2014-04-30 | A kind of for Chinese medicine composition treating thrombophlebitis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104288270B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721293A (en) * | 2015-02-15 | 2015-06-24 | 路泽华 | Chinese medicinal preparation used for treating superficial phlebitis |
CN105596814A (en) * | 2015-11-16 | 2016-05-25 | 孙绪连 | Traditional Chinese medicine smoked lotion for treating thrombophlebitis |
RU2791373C1 (en) * | 2022-05-04 | 2023-03-07 | Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" | Method for treatment and prevention of recurrent venous thrombosis after the novel coronavirus infection |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961729A (en) * | 2012-12-18 | 2013-03-13 | 王涛 | Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis |
-
2014
- 2014-04-30 CN CN201410181801.2A patent/CN104288270B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961729A (en) * | 2012-12-18 | 2013-03-13 | 王涛 | Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis |
Non-Patent Citations (2)
Title |
---|
吴超杰等,: "四妙勇安汤加味治疗髂股静脉血栓形成28例", 《陕西中医》 * |
陆炯: "活血化瘀10 法", 《中国中医药报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721293A (en) * | 2015-02-15 | 2015-06-24 | 路泽华 | Chinese medicinal preparation used for treating superficial phlebitis |
CN104721293B (en) * | 2015-02-15 | 2017-08-15 | 路泽华 | A kind of Chinese medicine preparation for treating shallow phlebitis |
CN105596814A (en) * | 2015-11-16 | 2016-05-25 | 孙绪连 | Traditional Chinese medicine smoked lotion for treating thrombophlebitis |
RU2791373C1 (en) * | 2022-05-04 | 2023-03-07 | Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" | Method for treatment and prevention of recurrent venous thrombosis after the novel coronavirus infection |
Also Published As
Publication number | Publication date |
---|---|
CN104288270B (en) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103961521A (en) | Traditional Chinese medicine composition for treating aplastic anemia and preparation method | |
CN105250619A (en) | Traditional Chinese medicine for treating intrinsic endometriosis and preparation method thereof | |
CN108478767A (en) | Plaster for treating joint swelling and pain | |
CN104288270A (en) | Traditional Chinese medicine composition for treating thrombophlebitis, and preparation method thereof | |
CN102716376A (en) | Chinese patent medicine and TCM decoction capable of effectively curing acute appendicitis | |
CN105395842A (en) | Traditional Chinese medicine composition for treating diabetes and oral preparation and preparation method thereof | |
CN107753602A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof | |
CN104324310A (en) | Traditional Chinese medicine composition for treating mycotic keratitis after immune suppression and preparation method thereof | |
CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
CN104758754A (en) | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof | |
CN103585366A (en) | Medicine for treating ischemic hyperlipidemia and preparation method thereof | |
CN108578607A (en) | A kind of pharmaceutical composition for treating kidney stone | |
CN103816450B (en) | A kind of Chinese medicine for the treatment of rheumatoid arthritis | |
CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof | |
CN106511688A (en) | Traditional Chinese medicine composition for treating cesarean scar pregnancy and placenta accrete, and preparation method and administering method thereof | |
CN104873780A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN104606462A (en) | Medicine for conditioning alcoholic fatty liver and preparation method of medicine | |
CN105169277A (en) | Fructus gardeniae oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN104257813A (en) | Traditional Chinese medicine composition for conditioning vital energy and blood and preparation method of traditional Chinese medicine composition | |
CN102895475B (en) | Plaster for treating chloasma and preparation method thereof | |
CN102895474B (en) | Powder for treating chloasma and preparation method for powder | |
CN104208218B (en) | A kind of Chinese medicine for the treatment of stagnant heat type amenorrhea | |
CN103520403B (en) | Traditional Chinese medicine for treating type II diabetes | |
CN103520631A (en) | Traditional Chinese medicine used for treating irregular menstruation | |
CN105434715A (en) | Traditional Chinese medicine enema liquid used for treating pelvic inflammation, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 Termination date: 20190430 |